Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Randomised Blinded Investigation of Cardioversion Versus Ablation for Persistent Atrial Fibrillation (ORBICA-AF)

NCT06096246 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT06096246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06096246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Randomised Blinded Investigation of Cardioversion Versus Ablation for Persistent Atrial Fibrillation (ORBICA-AF)
Lead sponsor
Barts & The London NHS Trust
Phase
Not applicable
Overall status
Recruiting
Start date
July 26, 2024
Completion date
December 5, 2027
Enrollment
208 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrhythmia, catheter ablation, persistent atrial fibrillation